VCYT•benzinga•
Diagnostic Company Veracyte Weighs Sale For French Subsidiary, Analyst Says 'Walking Away' Is A Long-Term Positive
Summary
Veracyte topped Q4 earnings and revenue estimates as testing volume grew. The company is evaluating options for its French unit.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 25, 2025 by benzinga